Hippocampus-targeted BDNF gene therapy to rescue cognitive impairments of AD in multiple mouse models. APP/PS1, rTg4510, 3 × Tg AD mouse models and adult male Cynomolgus macaque. Here, APP is linked to Cognitive impairment.